OOIR: Observatory of International Research

Papers

(The H4-Index of AIDS is 25. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)

Article	Citations
The need to avert emergent resistance to dolutegravir in children and adolescents with HIV	105
A randomized clinical trial of on-demand oral pre-exposure prophylaxis does not modulate lymphoid/myeloid HIV target cell density in the foreskin	94
Strategies for managing weight gain associated with antiretroviral therapy: switch or add?	75
Evaluation of HIV-1 reservoir size and broadly neutralizing antibody susceptibility in acute antiretroviral therapy-treated individuals	44
Gut microbiota and plasma metabolites associated with bone mineral density in women with or at risk of HIV infection	44
Social context and tracing household wealth over time in rural Uganda 1994–2018	44
Impact of pre-antiretroviral treatment HIV-RNA on time to successful virological suppression and subsequent virological failure – two nationwide, population-based cohort studies	40
Key milestones and participant engagement strategies in research with HIV-affected adolescents and young adults from low-to-middle income countries	39
High-level dolutegravir resistance can emerge rapidly from few variants and spread by recombination: implications for INSTI salvage therapy	36
Trends in population HIV viral suppression: a longitudinal analysis	35
Keeping up with Streptococcus pneumoniae in children living with HIV: Erratum	34
Comparison of dolutegravir and efavirenz on depression, anxiety and sleep disorders in pregnant and postpartum women living with HIV	32
A new frontier in HIV care: the predictive power of renal biomarkers on heart health	31
Virtual case management: a differentiated approach to HIV prevention, treatment, and care	31
Quantifying missed opportunities for tuberculosis among people with HIV in the US President's Emergency Plan for AIDS Relief	30
Diagnostic accuracy of the re-engineered urinary FujiLAM2 assay amongst hospitalized adults with advanced HIV disease	30
Elevated stress-responsive biomarkers are associated with HIV acquisition in young women in rural South Africa	30
Life expectancy of people with HIV on antiretroviral therapy in Spain	29
Factors influencing antiretroviral therapy switching in people with virologically suppressed HIV-1: a cross-sectional multicenter study in France	29
Incidence and risk factors for recurrent sexually transmitted infections among MSM on HIV pre-exposure prophylaxis	28
Real world use of dolutegravir two drug regimens	27
Associations between social determinants of health and comorbidity and multimorbidity in people of black ethnicities with HIV	27
Reduced bone density accrual among peripubertal boys with HIV in Zimbabwe: Erratum	26
Systemic inflammation in pregnant women with HIV: relationship with HIV treatment regimen and preterm delivery	26
Long-term persistence of transcriptionally active ‘defective’ HIV-1 proviruses: implications for persistent immune activation during antiretroviral therapy	25

Prevalence and risk factors of nonalcoholic steatohepatitis with significant fibrosis in people with HIV	25
Explaining racial and ethnic disparities in antiretroviral therapy adherence and viral suppression among U.S. men who have sex with men	25